Literature DB >> 17354203

Metabolic syndrome in polycystic ovary syndrome.

Thomas M Barber1, Mark I McCarthy, Stephen Franks, John A H Wass.   

Abstract

Both metabolic syndrome (MS) and polycystic ovary syndrome (PCOS) are common among women. The exact prevalence of MS in women with PCOS is dependent upon the diagnostic criteria used for each. However, the frequent co-occurrence of both MS and PCOS in women is suggestive of a common aetiology. In this short review article we argue that insulin resistance, as a consequence of abdominal obesity, may represent such a common aetiology. We also review the literature on the prevalence of MS in women with PCOS and consider the impact that the particular criteria used to diagnose both MS and PCOS may have had on these estimates of prevalence.

Entities:  

Mesh:

Year:  2007        PMID: 17354203

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  12 in total

1.  Euglena gracilis deoxyribonucleic acid polymerases: subcellular locations and variations during the cell cycle.

Authors:  A G McLennan; H M Keir
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

2.  Effect of overweight/obesity on IVF-ET outcomes in chinese patients with polycystic ovary syndrome.

Authors:  Kai Huang; Xiuhua Liao; Xiyuan Dong; Hanwang Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Effect of GnRHR polymorphisms on in vitro fertilization and embryo transfer in patients with polycystic ovary syndrome.

Authors:  Wei-Yan Chen; Yan-Qiu Du; Xia Guan; Hong-Yun Zhang; Ting Liu
Journal:  J Hum Genet       Date:  2017-09-07       Impact factor: 3.172

4.  Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females.

Authors:  V Padmanabhan; A Veiga-Lopez; D H Abbott; S E Recabarren; C Herkimer
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

5.  Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies.

Authors:  Hind A Beydoun; Laurel Stadtmauer; May A Beydoun; Helena Russell; Yueqin Zhao; Sergio Oehninger
Journal:  Reprod Biomed Online       Date:  2009-06       Impact factor: 3.828

6.  Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.

Authors:  Anindya Dasgupta; Aparna Khan; Ushasi Banerjee; Mrinalkanti Ghosh; Mrinal Pal; Kanika M Chowdhury; Sayantan Dasgupta
Journal:  Indian J Clin Biochem       Date:  2012-09-14

7.  The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level.

Authors:  Zhiqin Bu; Kakei Kuok; Jie Meng; Rui Wang; Bei Xu; Hanwang Zhang
Journal:  Reprod Biol Endocrinol       Date:  2012-02-06       Impact factor: 5.211

Review 8.  Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.

Authors:  Thomas M Barber; George K Dimitriadis; Avgi Andreou; Stephen Franks
Journal:  Clin Med (Lond)       Date:  2016-06       Impact factor: 2.659

9.  Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome.

Authors:  Myint Myint Aye; Eric S Kilpatrick; Ahmed Aburima; Katie S Wraith; Simbarashe Magwenzi; B Spurgeon; Alan S Rigby; Derek Sandeman; Khalid M Naseem; Stephen L Atkin
Journal:  J Am Heart Assoc       Date:  2014-02-28       Impact factor: 5.501

Review 10.  Obesity: novel and unusual predisposing factors.

Authors:  Petra Hanson; Martin O Weickert; Thomas M Barber
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-19       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.